New study to test HIV prevention safety for moms and babies in malawi
NCT ID NCT06158126
First seen May 11, 2026 · Last updated May 16, 2026 · Updated 2 times
Summary
This study looks at whether two HIV prevention methods—a long-acting shot and daily pills—are safe for pregnant women and their infants in Malawi. About 621 pregnant women already using or starting HIV prevention will choose either the shot or pills and be followed through pregnancy, birth, and breastfeeding. The goal is to see if there are differences in pregnancy problems, like miscarriage or preterm birth, between the two groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bwaila Distict Hospital
RECRUITINGLilongwe, Malawi
Conditions
Explore the condition pages connected to this study.